Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $77.6M $79.0M $70.0M $56.8M $34.9M $9.9M $13.6M $10.6M
Accounts Receivable $37.0M $35.9M — — — — — —
Inventory $116.6M $38.7M — — — — — —
Total Current Assets $520.3M $491.0M $341.3M $180.2M $187.2M $199.9M $141.6M $166.1M
Property, Plant & Equipment $884.0K $1.3M $1.2M $793.0K $650.0K $658.0K $408.0K $59.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $570.5M $593.8M $394.1M $190.6M $226.0M $270.7M $165.5M $185.3M
Liabilities
Accounts Payable $11.3M $8.6M $6.2M $10.2M $6.7M $6.9M $1.2M $982.0K
Total Current Liabilities $111.5M $88.3M $108.1M $76.7M $45.5M $30.9M $28.2M $7.6M
Long-Term Debt $119.5M $118.5M $35.1M $30.2M $49.8M $24.0M — —
Total Liabilities $344.7M $313.5M $146.1M $110.6M $99.6M $59.8M $30.4M $7.6M
Stockholders' Equity
Retained Earnings $-1.86B $-1.77B $-1.60B $-1.41B $-1.27B $-1.16B $-1.08B $-1.01B
Total Stockholders' Equity $225.9M $280.3M $247.9M $80.0M $126.4M $210.9M $135.2M $177.7M
← Newer Page 1 of 2 Older →